summary
Introduced
01/08/2024
01/08/2024
In Committee
01/26/2024
01/26/2024
Crossed Over
Passed
Dead
04/12/2024
04/12/2024
Introduced Session
2023-2024 Regular Session
Bill Summary
AN ACT Relating to accessing an emergency supply of insulin; and 2 adding new sections to chapter 70.330 RCW. 3
AI Summary
This bill establishes an emergency insulin program within the Prescription Drug Purchasing Consortium in Washington state. The program will allow eligible individuals, who are not enrolled in medical assistance or prescription drug coverage that limits their out-of-pocket costs for insulin to $35 or less, to access a 30-day supply of insulin for a maximum of $10 out-of-pocket. The Health Care Authority will manage the program and set up a process for individuals to attest to their eligibility. Network pharmacies will dispense the insulin and be reimbursed by the Consortium, which will then invoice the insulin manufacturers for the cost. The Authority can fine manufacturers up to $10,000 for failing to remit payment within 30 days. The bill also requires the Authority to provide information on manufacturer patient assistance programs that offer insulin at reduced or no cost.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (18)
Karen Keiser (D)*,
Annette Cleveland (D),
Steve Conway (D),
Manka Dhingra (D),
Bob Hasegawa (D),
Sam Hunt (D),
Claudia Kauffman (D),
Patty Kuderer (D),
John Lovick (D),
Mark Mullet (D),
Joe Nguyen (D),
T'wina Nobles (D),
Emily Randall (D),
Jesse Salomon (D),
Derek Stanford (D),
Javier Valdez (D),
Kevin Van De Wege (D),
Claire Wilson (D),
Last Action
Public hearing in the Senate Committee on Ways & Means at 1:30 PM. (on 02/02/2024)
Bill Topics
Health
- ‐ Regulation of Drug Industry and Pharmacies
- ‐ Treatment of Specific Diseases
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...